A study by Robman and colleagues investigating an association between exposure to Cpn infection and progression of AMD in patients aged 51–89 found that the rate of AMD progression over a 7-year period was increased in those with higher Cpn antibody titers [62]. This evidence concerns the gene CPN1 and age-related macular degeneration.